Evidence map›Paper›PMID 37344436›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Left Atrial Appendage Closure with the Watchman FLX System in a Patient with Hypertrophic Cardiomyopathy on Dialysis for End-stage Renal Failure.

Takashi Funaki, Mike Saji, Mai Terada, Itaru Takamisawa, Mamoru Nanasato, Takehiko Nagao, Takanori Ikeda, Mitsuaki Isobe

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Takashi FunakiDepartment of Cardiology, Sakakibara Heart Institute, Japan.
Mike SajiDepartment of Cardiology, Sakakibara Heart Institute, Japan.
Mai TeradaDepartment of Cardiology, Sakakibara Heart Institute, Japan.
Itaru TakamisawaDepartment of Cardiology, Sakakibara Heart Institute, Japan.
Mamoru NanasatoDepartment of Cardiology, Sakakibara Heart Institute, Japan.
Takehiko NagaoDepartment of Neurology, Nippon Medical School Musashikosugi Hospital, Japan.
Takanori IkedaDepartment of Cardiovascular Medicine, Toho University Faculty of Medicine, Japan.
Mitsuaki IsobeSakakibara Heart Institute, Japan.
Sakakibara Hospital · JPToho University · JPNippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with hypertrophic cardiomyopathy (HCM) often have atrial fibrillation, and empiric anticoagulation is recommended in these patients, regardless of other risk factors. However, anticoagulation is not recommended for patients who require hemodialysis (HD) because of the high bleeding risk. We herein report a case of left atrial appendage closure (LAAC) using the Watchman FLX system for a dilated phase HCM patient complicated by persistent atrial fibrillation and requiring HD. LAAC with the Watchman FLX system may be an alternative to antithrombotic medications in patients with dilated HCM complicated by atrial fibrillation and requiring HD.

Indexed as

Atrial AppendageAtrial FibrillationCardiomyopathy, HypertrophicKidney Failure, ChronicStrokeAnticoagulantsHumansLeft Atrial Appendage ClosureRenal DialysisTreatment OutcomeAnticoagulantshemodialysishypertrophic cardiomyopathyleft atrial appendage closure

Identifiers

PMID37344436
PMCPMC10901701
OpenAlexW4381431386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.